These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

749 related items for PubMed ID: 21888025

  • 1. C-reactive protein and complement components but not other acute-phase reactants discriminate between clinical subsets and organ damage in systemic lupus erythematosus.
    Amezcua-Guerra LM, Springall R, Arrieta-Alvarado AA, Rodríguez V, Rivera-Martinez E, Castillo-Martinez D, Bojalil R.
    Clin Lab; 2011; 57(7-8):607-13. PubMed ID: 21888025
    [Abstract] [Full Text] [Related]

  • 2. Systemic lupus erythmatosus - When to consider and management options.
    Apostolopoulos D, Hoi AY.
    Aust Fam Physician; 2013 Oct; 42(10):696-700. PubMed ID: 24130970
    [Abstract] [Full Text] [Related]

  • 3. Elevated semaphorin5A in systemic lupus erythematosus is in association with disease activity and lupus nephritis.
    Du Y, Wu X, Chen M, Wang W, Xv W, Ye L, Wu D, Xue J, Sun W, Luo J, Wu H.
    Clin Exp Immunol; 2017 May; 188(2):234-242. PubMed ID: 28063160
    [Abstract] [Full Text] [Related]

  • 4. Metabolic syndrome is associated with increased arterial stiffness and biomarkers of subclinical atherosclerosis in patients with systemic lupus erythematosus.
    Sabio JM, Vargas-Hitos J, Zamora-Pasadas M, Mediavilla JD, Navarrete N, Ramirez A, Hidalgo-Tenorio C, Jáimez L, Martín J, Jiménez-Alonso J, Grupo Lupus Virgen de las Nieves.
    J Rheumatol; 2009 Oct; 36(10):2204-11. PubMed ID: 19723903
    [Abstract] [Full Text] [Related]

  • 5. Hematocrit Level could Reflect Inflammatory Response and Disease Activity in Patients with Systemic Lupus Erythematosus.
    Yang M, Ma N, Fu H, Wei T, Tang Q, Qin B, Yang Z, Zhong R.
    Clin Lab; 2015 Oct; 61(7):801-7. PubMed ID: 26299080
    [Abstract] [Full Text] [Related]

  • 6. C-reactive protein is a more sensitive and specific marker for diagnosing bacterial infections in systemic lupus erythematosus compared to S100A8/A9 and procalcitonin.
    Kim HA, Jeon JY, An JM, Koh BR, Suh CH.
    J Rheumatol; 2012 Apr; 39(4):728-34. PubMed ID: 22337236
    [Abstract] [Full Text] [Related]

  • 7. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Figueredo MA, Rodriguez A, Ruiz-Yagüe M, Romero M, Fernandez-Cruz A, Gomez-de la Concha E, Patiño R.
    J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
    [Abstract] [Full Text] [Related]

  • 8. Serum levels of vascular endothelial growth factor in children and adolescents with systemic lupus erythematosus.
    Heshmat NM, El-Kerdany TH.
    Pediatr Allergy Immunol; 2007 Jun; 18(4):346-53. PubMed ID: 17346298
    [Abstract] [Full Text] [Related]

  • 9. Comparison of urinary parameters, biomarkers, and outcome of childhood systemic lupus erythematosus early onset-lupus nephritis.
    Miguel DF, Terreri MT, Pereira RMR, Bonfá E, Silva CAA, Corrente JE, Magalhaes CS, Brazilian Childhood-onset Systemic Lupus Erythematosus Group.
    Adv Rheumatol; 2020 Feb 01; 60(1):10. PubMed ID: 32005292
    [Abstract] [Full Text] [Related]

  • 10. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
    Mahmoud RA, El-Gendi HI, Ahmed HH.
    Clin Biochem; 2005 Feb 01; 38(2):134-41. PubMed ID: 15642275
    [Abstract] [Full Text] [Related]

  • 11. Low complements and high titre of anti-Sm antibody as predictors of histopathologically proven silent lupus nephritis without abnormal urinalysis in patients with systemic lupus erythematosus.
    Ishizaki J, Saito K, Nawata M, Mizuno Y, Tokunaga M, Sawamukai N, Tamura M, Hirata S, Yamaoka K, Hasegawa H, Tanaka Y.
    Rheumatology (Oxford); 2015 Mar 01; 54(3):405-12. PubMed ID: 25183834
    [Abstract] [Full Text] [Related]

  • 12. Urine β2-microglobulin is associated with clinical disease activity and renal involvement in female patients with systemic lupus erythematosus.
    Choe JY, Park SH, Kim SK.
    Lupus; 2014 Dec 01; 23(14):1486-93. PubMed ID: 25124677
    [Abstract] [Full Text] [Related]

  • 13. Differential approach to peripheral blood cell ratios in patients with systemic lupus erythematosus and various manifestations.
    Suszek D, Górak A, Majdan M.
    Rheumatol Int; 2020 Oct 01; 40(10):1625-1629. PubMed ID: 32772131
    [Abstract] [Full Text] [Related]

  • 14. Serum ferritin level correlates with SLEDAI scores and renal involvement in SLE.
    Tripathy R, Panda AK, Das BK.
    Lupus; 2015 Jan 01; 24(1):82-9. PubMed ID: 25253568
    [Abstract] [Full Text] [Related]

  • 15. Pentraxin-3 levels are associated with vasculitis and disease activity in childhood-onset systemic lupus erythematosus.
    Sahin S, Adrovic A, Barut K, Durmus S, Gelisgen R, Uzun H, Kasapcopur O.
    Lupus; 2017 Sep 01; 26(10):1089-1094. PubMed ID: 28420068
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?
    de Carvalho JF, Borba EF, Viana VS, Bueno C, Leon EP, Bonfá E.
    Arthritis Rheum; 2004 Nov 01; 50(11):3610-5. PubMed ID: 15529371
    [Abstract] [Full Text] [Related]

  • 18. Vasculitis in systemic lupus erythematosus (SLE)--assessment of peripheral blood mononuclear cell activation and the degree of endothelial dysfunction: initial report.
    Kluz J, Kopeć W, Jakobsche U, Prajs I, Adamiec R.
    Postepy Hig Med Dosw (Online); 2007 Dec 03; 61():725-35. PubMed ID: 18063917
    [Abstract] [Full Text] [Related]

  • 19. Decreased serum levels of TGF-β1 are associated with renal damage in female patients with systemic lupus erythematosus.
    Jin T, Almehed K, Carlsten H, Forsblad-d'Elia H.
    Lupus; 2012 Mar 03; 21(3):310-8. PubMed ID: 22072025
    [Abstract] [Full Text] [Related]

  • 20. Relationship between serum acute-phase proteins and high disease activity in patients with rheumatoid arthritis.
    Cylwik B, Chrostek L, Gindzienska-Sieskiewicz E, Sierakowski S, Szmitkowski M.
    Adv Med Sci; 2010 Mar 03; 55(1):80-5. PubMed ID: 20371432
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.